Studies on the effect of long-term use of low dose aspirin in Kawasaki disease.
Hamasaki
Y
Y
Ichimaru
T
T
Tasaki
H
H
Miyazaki
S
S
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001241:Aspirin / Q000627:therapeutic use*; D002675:Child, Preschool; D003094:Collagen / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D011464:Epoprostenol / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy*; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D011453:Prostaglandins / Q000378:metabolism*; D011460:Prostaglandins F / Q000378:metabolism; D013928:Thromboxane A2 / Q000378:metabolism; D013929:Thromboxane B2 / Q000378:metabolism; D013997:Time Factors
D010975:Platelet Aggregation Inhibitors; D011453:Prostaglandins; D011460:Prostaglandins F; D013929:Thromboxane B2; D013928:Thromboxane A2; D000244:Adenosine Diphosphate; D003094:Collagen; D011464:Epoprostenol; D001241:Aspirin; D004837:Epinephrine